BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 10684364)

  • 1. Hemostatic problems and thromboembolic complications in nephrotic children.
    Citak A; Emre S; Sâirin A; Bilge I; Nayir A
    Pediatr Nephrol; 2000 Feb; 14(2):138-42. PubMed ID: 10684364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemostatic profile in nephrotic syndrome.
    Anand NK; Chand G; Talib VH; Chellani H; Pande J
    Indian Pediatr; 1996 Dec; 33(12):1005-12. PubMed ID: 9141800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Natural coagulation inhibitors; antithrombin III, protein C, protein S in children with hypercoagulation due to nephrotic syndrome].
    Wygledowska G; Grygalewicz J; Matuszewska E
    Med Wieku Rozwoj; 2001; 5(4):377-88. PubMed ID: 12004145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboembolic complications in children with nephrotic syndrome. Risk and incidence.
    Hoyer PF; Gonda S; Barthels M; Krohn HP; Brodehl J
    Acta Paediatr Scand; 1986 Sep; 75(5):804-10. PubMed ID: 2436435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylaxis with AT III for thromboembolism in nephrotic syndrome: why should it be done?
    Zaffanello M; Brugnara M; Fanos V; Franchini M
    Int Urol Nephrol; 2009; 41(3):713-6. PubMed ID: 18696250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboembolic risk in children with nephrotic syndrome.
    De Mattia D; Penza R; Giordano P; Di Bitonto G; Altomare M; Del Vecchio GC; Schettini F
    Haemostasis; 1991; 21(5):300-4. PubMed ID: 1806458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombin III level in children with nephrotic syndrome, its correlation to thromboembolic complications, and serum albumin level.
    Hussein SK; Mohammed AH; Mohammed RA; Abdelghafar H
    Saudi J Kidney Dis Transpl; 2021; 32(5):1283-1288. PubMed ID: 35532697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombin III and the nephrotic syndrome.
    Jørgensen KA; Stoffersen E
    Scand J Haematol; 1979 May; 22(5):442-8. PubMed ID: 472663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombin III (AT III) and fibrinogen levels in nephrotic syndrome in children.
    Elidrissy AT; Gader AM
    Haemostasis; 1985; 15(6):384-8. PubMed ID: 4076845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemostasis and thromboembolism in children with nephrotic syndrome: differences from adults.
    Mehls O; Andrassy K; Koderisch J; Herzog U; Ritz E
    J Pediatr; 1987 Jun; 110(6):862-7. PubMed ID: 3585601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein C and protein S in pediatric nephrotic patients.
    Yermiahu T; Shalev H; Landau D; Dvilansky A
    Sangre (Barc); 1996 Apr; 41(2):155-7. PubMed ID: 9045358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasma and urinary antithrombin III in the nephrotic syndrome in adults].
    Antelin CH; Gouault-Heilmann M; Levent M; Bernard D; Ruszniewski P; Lagrue G
    Ann Med Interne (Paris); 1983; 134(8):713-6. PubMed ID: 6666909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced alpha-2-antiplasmin levels in the nephrotic syndrome.
    Francis RB; Sandler RM; Levitan D; Feinstein EI; Massry SG; Feinstein DI
    Nephron; 1985; 39(4):325-9. PubMed ID: 3157072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case series of thromboembolic complications in childhood nephrotic syndrome: Hacettepe experience.
    Tavil B; Kara F; Topaloglu R; Aytac S; Unal S; Kuskonmaz B; Cetin M; Besbas N; Gumruk F
    Clin Exp Nephrol; 2015 Jun; 19(3):506-13. PubMed ID: 24993948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemostatic parameters in childhood nephrotic syndrome. (Is there any difference in protein C levels between steroid sensitive and resistant groups?).
    Yalçinkaya F; Tümer N; Gorgani AN; Ekim M; Cakar N
    Int Urol Nephrol; 1995; 27(5):643-7. PubMed ID: 8775051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult patients with the nephrotic syndrome: really at high risk for deep venous thromboembolism? Report of a series and review of the literature.
    Ruggeri M; Milan M; La Greca G; Castaman G; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):47-51. PubMed ID: 8039758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Concentration of tissue plasminogen activator and its inhibitor 1 in cyclosporine A-treated children with idiopathic nephrotic syndrome].
    Tkaczyk M; Owczarek D; Finke D; Nowicki M
    Pol Merkur Lekarski; 2003 Apr; 14(82):315-8. PubMed ID: 12868191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome.
    Llach F
    Kidney Int; 1985 Sep; 28(3):429-39. PubMed ID: 3906225
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
    Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
    Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antithrombin III in infantile nephrotic syndrome].
    Lorusso L; Miniello VL; Francioso G; Aceto G; DiBitonto G; Penza R
    Boll Soc Ital Biol Sper; 1982 Sep; 58(17):1093. PubMed ID: 7138678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.